XXII

4.95

4.65% 0.22

Dopo l'orario di chiusura: 5.03 0.08 +1.62%

22nd Century Group, Inc. (XXII)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Forum Previsione Frazionamento azionario

Precedente Chiudi:

$4.73

Aprire:

$4.74

Volume 24 ore:

101.99K

Relative Volume:

1.52

Capitalizzazione di mercato:

$2.74M

Reddito:

$29.78M

Utile/perdita netta:

$-39.94M

Rapporto P/E:

-0.934

EPS:

-5.3

Flusso di cassa netto:

$-16.12M

1 W Prestazione:

-25.32%

1M Prestazione:

-62.20%

6M Prestazione:

-93.89%

1 anno Prestazione:

-98.83%

Intervallo 1D:

$4.61

$5.28

Intervallo di 1 settimana:

$3.90

$6.075

Portata 52W:

$3.90

$581.85

22nd Century Group, Inc. Stock (XXII) Company Profile

Nome

22nd Century Group, Inc.

Settore

Healthcare (1176)

Industria

Biotechnology (673)

Telefono

716-270-1523

Indirizzo

8560 Main Street, Williamsville, NY

Dipendente

Cinguettio

@_xxiicentury

Prossima data di guadagno

2024-12-12

Ultimi documenti SEC

XXII's Discussions on Twitter

Confronta XXII con altri titoli

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
XXII 22nd Century Group, Inc.	4.95	2.74M	29.78M	-39.94M	-16.12M	-61.91
VRTX Vertex Pharmaceuticals Inc	397.27	102.31B	10.63B	-479.80M	-1.35B	-1.99
REGN Regeneron Pharmaceuticals Inc	701.85	77.13B	13.85B	4.65B	3.32B	40.41
ARGX Argen X Se Adr	623.82	37.30B	1.86B	-40.29M	-1.28B	-0.85
ALNY Alnylam Pharmaceuticals Inc	245.44	31.66B	2.09B	-332.26M	16.06M	-2.62
BNTX Biontech Se Adr	113.08	27.11B	3.30B	-501.07M	1.03B	-2.1146

22nd Century Group, Inc. Stock (XXII) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2022-07-21	Iniziato	Alliance Global Partners	Buy
2022-06-15	Iniziato	Craig Hallum	Buy
2022-03-08	Iniziato	ROTH Capital	Buy
2021-07-23	Iniziato	Cowen	Outperform
2017-10-16	Reiterato	Chardan Capital Markets	Buy
2016-08-11	Reiterato	Chardan Capital Markets	Buy

Mostra tutto

22nd Century Group, Inc. Borsa (XXII) Ultime notizie

Dec 19, 2024

StockNews.com Begins Coverage on 22nd Century Group (NASDAQ:XXII) - MarketBeat

Dec 19, 2024

Dec 18, 2024

22nd Century Group announces reverse stock split - Investing.com

Dec 18, 2024

22nd Century Group announces reverse stock split By Investing.com - Investing.com UK

Dec 18, 2024

Dec 16, 2024

22nd Century : Appoints Leading Plant Biotechnology Expert Dr. Michael Koganov to Board of Directors - Marketscreener.com

Dec 16, 2024

22Nd Century Group Expands VLN Tobacco Growing Program to Support Anticipated Demand of the Company’S Reduced Nicotine Content Cigarettes - Marketscreener.com

Dec 16, 2024

22nd Century Group, Inc. Announces Chief Financial Officer Changes - Marketscreener.com

Dec 16, 2024

XXII Stock Plummets to 52-Week Low of $0.04 Amid Market Turbulence By Investing.com - Investing.com South Africa

Dec 16, 2024

22nd Century : Reduces Debt by Additional $1.5 Million via Payment from GVB Form 8 K - Marketscreener.com

Dec 16, 2024

Dec 15, 2024

22nd Century Group, Inc. announced that it expects to receive $1.6815 million in funding - Marketscreener.com

Dec 15, 2024

Dec 13, 2024

22nd Century Group (NASDAQ:XXII) Stock Quotes, Forecast and News Summary - Benzinga

Dec 13, 2024

22nd Century Applauds FDA Proposal to Mandate Reduced Nicotine Content in Cigarettes - The Kingston Whig-Standard

Dec 12, 2024

Toll Brothers Inc (TOL-N) QuotePress Release - The Globe and Mail

Dec 12, 2024

Dec 07, 2024

22nd Century Group approves reverse stock split By Investing.com - Investing.com Nigeria

Dec 07, 2024

22nd Century Group approves reverse stock split - Investing.com India

Dec 07, 2024

Nov 28, 2024

12 Cannabis Stocks to Buy Now in 2024 - MarketBeat

Nov 28, 2024

Nov 14, 2024

22nd Century Net Loss Widens - Tobacco Reporter

Nov 14, 2024

Nov 13, 2024

22nd Century: Q3 Earnings Snapshot - CT Insider

Nov 13, 2024

XXII stock plunges to 52-week low of $0.09 amid market challenges - Investing.com

Nov 13, 2024